Delivery Order SPE2DB22D3004-SPE2DB24FPC02
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,656.41 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pens. The contract has an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,854.04, is for the delivery of Dupixent, a 300 mg/2 ml pen medication, with an ultimate completion date of October 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $10,048.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml pens, a specialty medication, with a completion date of November 8, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $4,167.61, is a delivery order for Dupixent 300 mg/2 ml pens. The award has an ultimate completion date of February 15, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order worth $21,634.99 for the supply of Dupixent 300 mg/2 ml pens. It has an ultimate completion date of April 25, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,950.42 delivery order is for the supply of Dupixent 300 mg/2 ml pens. The contract has a firm fixed price and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of pharmaceutical products and medical supplies. The award, valued at $12,447.23, covers the delivery of Dupixent 300 mg/2 ml pens with an ultimate completion date of April 11, 2024. This contract is a delivery order and uses a firm fixed-price pricing type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dupixent 300 mg/2 ml pens. The fixed-price delivery order, valued at $9,914.10, has a completion date of March 13, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $14,978.98 delivery order contract is for Dupixent 300 mg/2 ml pens and has a completion date of February 12, 2024. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $13,395.44 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pens to support military healthcare programs. The contract has an ultimate completion date of January 30, 2024. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPC02Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,873.54, is for the delivery of Dupixent 300 mg/2 ml pens. This is a firm-fixed-price delivery order with a completion date of January 26, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This contract award is not designated as a set-aside and was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 1/25/24 |